Björn Hultberg

författare

• 2013
  • Elevated plasma homocysteine level in vascular dementia reflects the vascular disease process.
• 2012
  • Elevated Plasma Homocysteine Level Is Not Primarily Related to Alzheimer's Disease.
  • Plasma homocysteine, brain imaging and cognition in older patients with mental illness.
  • The use of N-terminal pro-brain natriuretic Peptide to evaluate vascular disease in elderly patients with mental illness.
• 2011
  • C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time.
  • Survival in a large elderly population of patients with dementia and other forms of psychogeriatric diseases.
• 2010
  • Plasma Homocysteine and Cognition in Elderly Patients with Dementia or Other Psychogeriatric Diseases.
  • Plasma homocysteine, apolipoprotein E status and vascular disease in elderly patients with mental illness.
  • Plasma homocysteine-a marker of vascular disease in elderly patients with mental illness.
  • The clinical use of N-terminal-pro brain natriuretic peptide in elderly patients with mental illness.
• 2009
  • Association between plasma homocysteine levels and mortality in elderly patients with mental illness.
  • Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet
  • Plasma Homocysteine Levels and Different Forms of Vascular Disease in Patients with Dementia and Other Psychogeriatric Diseases.
• 2008
  • C-reactive protein: vascular risk marker in elderly patients with mental illness.
  • Homocystein--markör för kärlsjukdom hos aldre med psykisk sjukdom.
  • Homocysteine, cystatin C and N-terminal-pro brain natriuretic Peptide. Vascular risk markers in elderly patients with mental illness.
  • Kvalitetssäkring av patientnära blodgasanalyser ökade patientsäkerheten. Ackrediteringsprojekt i Lund föll väl ut.
  • Minireview: Plasma homocysteine and vascular disease in elderly patients with mental illness.
  • Plasma homocysteine and vascular disease in elderly patients with mental illness
• 2007
  • Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis
  • Oxidative stress decreases extracellular homocysteine concentration in human hepatoma (HepG2) cell cultures
  • Plasma Homocysteine Is Elevated in Elderly Patients with Memory Complaints and Vascular Disease.
  • Traces of copper ions deplete glutathione in human hepatoma cell cultures with low cysteine content
• 2006
  • Plasma Homocysteine and Vascular Disease in Psychogeriatric Patients.
  • Plasma Homocysteine, Cobalamin/Folate Status, and Vascular Disease in a Large Population of Psychogeriatric Patients.
  • The effect of different antioxidants on glutathione turnover in human cell lines and their interaction with hydrogen peroxide.
  • The effects of adrenocorticotrophic hormone and cortisol on homocysteine and vitamin B concentrations.
  • The polyphenol quercetin strongly increases homocysteine production in a human hepatoma (Hep G2) cell line.
• 2005
  • Bovine retinal pericytes are resistant to glucose-induced oxidative stress in vitro.
  • Elimination of high amounts of extracellular homocysteine in human cell lines.
  • Glutathione turnover in human cell lines in the presence of agents with glutathione influencing potential with and without acivicin inhibition of gamma-glutamyltranspeptidase.
  • Plasma Homocysteine Concentration and Its Relation to Symptoms of Vascular Disease in Psychogeriatric Patients.
  • Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
  • Plasma homocysteine and markers of bone metabolism in psychogeriatric patients.
• 2004
  • Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms.
  • Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport.
  • High glutathione turnover in human cell lines revealed by acivicin inhibition of gamma-glutamyltranspeptidase and the effects of thiol-reactive metals during acivicin inhibition.
  • Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
• 2003
  • Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading
  • Folate and cobalamin levels as determinants of plasma homocysteine in different age groups of healthy controls and psychogeriatric patients.
  • Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease.
  • Modulation of extracellular homocysteine concentration in human cell lines.
  • Optimal användning av markörer för kobalamin-/folatstatus. Resultat från utvärdering i en psykogeriatrisk patientgrupp
  • Risk of myocardial infarction in relation to plasma levels of homocysteine and inflammation-sensitive proteins: a long-term nested case-control study.
  • The effect of cyclosporine on homocysteine export in human cell lines.
  • The effect of vitamin B-12 on total plasma homocysteine concentration in folate-replete hemodialysis patients
• 2002
  • Folate deficiency is a common finding in psychogeriatric patients.
  • Lack of association between plasma homocysteine and inflammation in psychogeriatric patients
  • Lipoic acid increases glutathione production and enhances the effect of mercury in human cell lines.
  • Optimal use of markers for cobalamin and folate status in a psychogeriatric population.
  • Relation between plasma homocysteine and Alzheimer's disease.
  • Renal function exerts only a minor influence on high plasma homocysteine concentrations in patients with acute coronary syndromes.
  • The postdialytic rise in the plasma total homocysteine concentration is delayed
  • The redox state of glutathione, cysteine and homocysteine in the extracellular fluid in the skin.
  • Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia.
• 2001
  • Homocysteine and nephrotic syndrome - Reply
  • Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease
  • Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine
  • Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol
  • Isolated liver perfusion permits administration of high doses of chemotherapeutic agents. Comparison with hepatic artery infusion
  • Markers for the functional availability of cobalamin/folate and their association with neuropsychiatric symptoms in the elderly
  • Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy
• 2000
  • Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries
  • Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine
• 1999
  • Concentrations of plasma methylmalonic acid in 80-year-olds show only weak relation to psychological performance
• 1998
  • Glutathione levels are reduced in diabetic rat retina but are not influenced by ischemia followed by recirculation
  • Plasma homocysteine in 80-year-olds Relationships to medical, psychological and social variables.
  • The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment
• 1997
  • Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study
• 1996
  • Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients
  • The effect of reduced glomerular filtration rate on plasma total homocysteine concentration
• 1995
  • Plasma beta-hexosaminidase isoenzymes A and B exhibit different relations to blood glucose levels in a population of Type 1 diabetic patients
  • Plasma homocysteine in the acute and convalescent phases after stroke
• 1994
  • Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus
• 1991
  • Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus
  • Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus
  • The association between plasma beta-hexosaminidase and its isoenzyme patterns and retinopathy in type 1 diabetes mellitus
• 1987
  • Lack of relationship between beta-hexosaminidase activity and retinopathy in insulin dependent diabetics
• 1982
  • Serum beta-hexosaminidase in diabetes mellitus with reference to the type of treatment